Samuel B. Barone Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Samuel B. Barone.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Samuel B. Barone. Samuel B. Barone is a Chief Medical Officer in Adverum Biotechnologies, Inc. ($AAVL) and a SVP, Clinical Development in Adverum Biotechnologies, Inc. ($AAVL) and a Chief Medical Officer in Gemini Therapeutics, Inc. /DE ($FSDC).
Address: C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK 94025 CA
Companies in which Samuel B. Barone is an Insider
Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Samuel B. Barone: SVP, Clinical Development, Chief Medical Officer
Holdings: 172,335 shares
Latest Transaction: Feb 13 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gemini Therapeutics, Inc. /DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel B. Barone: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Apr 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Samuel B. Barone
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2021 | FSDC | Gemini Therapeutic ... | Barone Samuel B. | Chief Medical Offic ... | Option Exercise | A | 12.59 | 255,212 | 3,213,119 | 255,212 | |
| Feb 13 2017 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | SVP, Clinical Devel ... | Option Exercise | A | 2.70 | 84,000 | 226,800 | 84,000 | |
| Feb 13 2017 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | SVP, Clinical Devel ... | Grant | A | 0.00 | 58,000 | 0 | 172,335 | 114.3 K to 172.3 K (+50.73 %) |
| Jun 21 2016 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | SVP, Clinical Devel ... | Option Exercise | A | 3.31 | 50,000 | 165,500 | 50,000 | |
| Jun 21 2016 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | SVP, Clinical Devel ... | Grant | A | 0.00 | 20,000 | 0 | 114,335 | 94.3 K to 114.3 K (+21.20 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | Chief Medical Offic ... | Option Exercise | A | 4.80 | 75,000 | 360,000 | 75,000 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 91,603 | 41.6 K to 91.6 K (+120.18 %) |